EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): $0.15

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.16. In 2022 the company made an earnings per share (EPS) of $0.16 a decrease over its 2021 EPS that were of $0.19.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year	EPS	Change
2023 (TTM)	$0.15	-5.21%
2022	$0.16	-17.1%
2021	$0.19	-24.44%
2020	$0.25	20.3%
2019	$0.21	25.58%
2018	$0.17	27.55%
2017	$0.13	21.64%
2016	$0.11	13.57%
2015	$0.09453	39.86%
2014	$0.06759	21.33%
2013	$0.05571	17.7%
2012	$0.04733	25.56%
2011	$0.03770	26.22%
2010	$0.02986	10.3%
2009	$0.02708	57.92%
2008	$0.01715	11.06%
2007	$0.01544	85.81%
2006	$0.008308	87.94%
2005	$0.004421	33.97%
2004	$0.003300	29.78%
2003	$0.002542	19.78%
2002	$0.002122

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions